| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.890 | 8.933 | 394 | 689 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 11.890 | 8.933 | 394 | 689 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 6.607 | 4.501 | 1.078 | 636 | 0 | 290 | 159 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 5.283 | 4.432 | -684 | 54 | 0 | -290 | -159 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 4.926 | 4.164 | -696 | 33 | 0 | -290 | -159 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Farmmica Impex Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.634 | 1.329 | 1.023 | 726 | 461 | 162 | 0 | 0 | 0 | 0 |
| Current Assets | 4.707 | 9.271 | 7.918 | 8.018 | 8.053 | 7.714 | 7.725 | 7.749 | 7.726 | 7.682 |
| Inventories | 924 | 577 | 290 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 207 | 205 | 280 | 168 | 354 | 161 | 340 | 341 | 340 | 338 |
| Cash | 3.576 | 8.489 | 7.348 | 7.851 | 7.699 | 7.553 | 7.385 | 7.408 | 7.386 | 7.344 |
| Shareholders Funds | 4.980 | 9.093 | 3.450 | 3.419 | 3.103 | 2.754 | 2.534 | 2.542 | 2.534 | 2.520 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.362 | 1.507 | 5.492 | 5.325 | 5.412 | 5.123 | 5.191 | 5.208 | 5.192 | 5.163 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4778 - 4778" | |||||||||
| CAEN Financial Year |
4774
|
|||||||||
Comments - Farmmica Impex Srl